Compare FOLD & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | PAYO |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2007 | N/A |
| Metric | FOLD | PAYO |
|---|---|---|
| Price | $9.92 | $5.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $30.29 | $9.79 |
| AVG Volume (30 Days) | ★ 4.6M | 2.8M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $598,704,000.00 | ★ $1,039,820,000.00 |
| Revenue This Year | $21.12 | $11.18 |
| Revenue Next Year | $21.23 | $7.45 |
| P/E Ratio | ★ N/A | $31.18 |
| Revenue Growth | ★ 21.28 | 10.58 |
| 52 Week Low | $5.51 | $4.92 |
| 52 Week High | $10.57 | $11.19 |
| Indicator | FOLD | PAYO |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 49.24 |
| Support Level | $9.56 | $5.65 |
| Resistance Level | $10.05 | $5.87 |
| Average True Range (ATR) | 0.37 | 0.17 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 51.14 | 65.74 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.